Jonas Zaugg

Dr. Jonas Zaugg

University of Bern, Bern, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Development
Verified
Journal Article
Open access
PDF file
ABAlexa Burger
Alexa Burger
HLHelen Lindsay
Helen Lindsay
AFAnastasia Felker
Anastasia Felker
CHChristopher Hess
Christopher Hess
CACarolin Anders
Carolin Anders
CMChristian Mosimann
Christian Mosimann
CRISPR-Cas9 enables efficient sequence-specific mutagenesis for creating somatic or germline mutants of model organisms. Key constraints in vivo remain the expression and delivery of active Cas9-guideRNA ribonucleoprotein complexes (RNPs) with minimal toxicity, variable mutagenesis efficiencies depending on targeting sequence, and high mutation mosaicism. Here, we apply in vitro-assembled, fluorescent Cas9-sgRNA RNPs in solubilizing salt solution to achieve maximal mutagenesis efficiency in zebrafish embryos. MiSeq-based sequence analysis of targeted loci in individual embryos using CrispRVariants, a customized software tool for mutagenesis quantification and visualization, reveals efficient bi-allelic mutagenesis that reaches saturation at several tested gene loci. Such virtually complete mutagenesis exposes loss-of-function phenotypes for candidate genes in somatic mutant embryos for subsequent generation of stable germline mutants. We further show that targeting of non-coding elements in gene-regulatory regions using saturating mutagenesis uncovers functional control elements in transgenic reporters and endogenous genes in injected embryos. Our results establish that optimally solubilized, in vitro assembled fluorescent Cas9-sgRNA RNPs provide a reproducible reagent for direct and scalable loss-of-function studies and applications beyond zebrafish experiments that require maximal DNA cutting efficiency in vivo.

12 July 2016 in Nature Biotechnology
Verified
Journal Article
Closed access
HLHelen Lindsay
Helen Lindsay
ABAlexa Burger
Alexa Burger
BBBerthin Biyong
Berthin Biyong
AFAnastasia Felker
Anastasia Felker
CHChristopher Hess
Christopher Hess
MRMark D Robinson
Mark D Robinson

11 June 2022 in Cells
Verified
Journal Article
Open access
PDF file
BSBarbara Marlene Fuenzalida Saavedra
Barbara Marlene Fuenzalida Saavedra
SKSampada Kallol
Sampada Kallol
JZJonas Zaugg
Jonas Zaugg
MMMartin Mueller
Martin Mueller
HMHiten D Mistry
Hiten D Mistry
CAChristiane Albrecht
Christiane Albrecht
Preeclampsia (PE) is a pregnancy-specific disorder that affects 3 to 5% of pregnancies worldwide and is one of the leading causes of maternal and fetal morbidity and mortality. Nevertheless, how these events occur remains unclear. We hypothesized that the induction of hypoxic conditions in vitro in primary human trophoblast cells would mimic several characteristics of PE found in vivo. We applied and characterized a model of primary cytotrophoblasts isolated from healthy pregnancies that were placed under different oxygen concentrations: ambient O2 (5% pCO2, 21%pO2, 24 h, termed “normoxia”), low O2 concentration (5% pCO2, 1.5% pO2, 24 h, termed “hypoxia”), or “hypoxia/reoxygenation” (H/R: 6 h intervals of normoxia and hypoxia for 24 h). Various established preeclamptic markers were assessed in this cell model and compared to placental tissues obtained from PE pregnancies. Seventeen PE markers were analyzed by qPCR, and the protein secretion of soluble fms-like tyrosine kinase 1 (sFlT-1) and the placenta growth factor (PlGF) was determined by ELISA. Thirteen of seventeen genes associated with angiogenesis, the renin–angiotensin system, oxidative stress, endoplasmic reticulum stress, and the inflammasome complex were susceptible to H/R and hypoxia, mimicking the expression pattern of PE tissue. In cell culture supernatants, the secretion of sFlT-1 was increased in hypoxia, while PlGF release was significantly reduced in H/R and hypoxia. In the supernatants of our cell models, the sFlT-1/PlGF ratio in hypoxia and H/R was higher than 38, which is a strong indicator for PE in clinical practice. These results suggest that our cellular models reflect important pathological processes occurring in PE and are therefore suitable as PE in vitro models.

14 April 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
JZJonas Zaugg
Jonas Zaugg
HMHassan Melhem
Hassan Melhem
XHXiao Huang
Xiao Huang
MWMalgorzata Wegner
Malgorzata Wegner
MBMarc Baumann
Marc Baumann
CAChristiane Albrecht
Christiane Albrecht
Clinical studies suggest that pregnant women with elevated iron levels are more vulnerable to develop gestational diabetes mellitus (GDM), but the causes and underlying mechanisms are unknown. We hypothesized that hyperglycemia induces cellular stress responses leading to dysregulated placental iron homeostasis. Hence, we compared the expression of genes/proteins involved in iron homeostasis in placentae from GDM and healthy pregnancies (n = 11 each). RT‐qPCR and LC‐MS/MS analyses revealed differential regulation of iron transporters/receptors ( DMT1 / FPN1 / ZIP8 / TfR1 ), iron sensors ( IRP1 ), iron regulators ( HEPC ), and iron oxidoreductases ( HEPH / Zp ). To identify the underlying mechanisms, we adapted BeWo trophoblast cells to normoglycemic (N), hyperglycemic (H), and hyperglycemic‐hyperlipidemic (HL) conditions and assessed Fe 3+ ‐uptake, expression patterns, and cellular pathways involving oxidative stress (OS), ER‐stress, and autophagy. H and HL induced alterations in cellular morphology, differential iron transporter expression, and reduced Fe 3+ ‐uptake confirming the impact of hyperglycemia on iron transport observed in GDM patients. Pathway analysis and rescue experiments indicated that dysregulated OS and disturbed autophagy processes contribute to the reduced placental iron transport under hyperglycemic conditions. These adaptations could represent a protective mechanism preventing the oxidative damage for both fetus and placenta caused by highly oxidative iron. In pregnancies with risk for GDM, antioxidant treatment, and controlled iron supplementation could help to balance placental OS levels protecting mother and fetus from impaired iron homeostasis.

23 April 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSMariana Schroeder
Mariana Schroeder
MJMira Jakovcevski
Mira Jakovcevski
TPTamar Polacheck
Tamar Polacheck
YDYonat Drori
Yonat Drori
ALAlessia Luoni
Alessia Luoni
ACAlon Chen
Alon Chen
Anorexia nervosa (AN) is a devastating eating disorder characterized by self-starvation that mainly affects women. Its etiology is unknown, which impedes successful treatment options leading to a limited chance of full recovery. Here, we show that gestation is a vulnerable window that can influence the predisposition to AN. By screening placental microRNA expression of naive and prenatally stressed (PNS) fetuses and assessing vulnerability to activity-based anorexia (ABA), we identify miR-340 as a sexually dimorphic regulator involved in prenatal programming of ABA. PNS caused gene-body hypermethylation of placental miR-340, which is associated with reduced miR-340 expression and increased protein levels of several target transcripts, GR, Cry2 and H3F3b. MiR-340 is linked to the expression of several nutrient transporters both in mice and human placentas. Using placenta-specific lentiviral transgenes and embryo transfer, we demonstrate the key role miR-340 plays in the mechanism involved in early life programming of ABA.

Verified
Journal Article
Open access
PDF file
EOEdgar Ontsouka
Edgar Ontsouka
AEAlessandra Epstein
Alessandra Epstein
SKSampada Kallol
Sampada Kallol
JZJonas Zaugg
Jonas Zaugg
MBMarc U. Baumann
Marc U. Baumann
CAChristiane Albrecht
Christiane Albrecht
Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-related condition characterized by increased maternal circulating bile acids (BAs) having adverse fetal effects. We investigated whether the human placenta expresses specific regulation patterns to prevent fetal exposition to harmful amounts of BAs during ICP. Using real-time quantitative PCR, we screened placentae from healthy pregnancies (n = 12) and corresponding trophoblast cells (n = 3) for the expression of 21 solute carriers and ATP-binding cassette transporter proteins, all acknowledged as BA- and/or cholestasis-related genes. The placental gene expression pattern was compared between healthy women and ICP patients (n = 12 each). Placental SLCO3A1 (OATP3A1) gene expression was significantly altered in ICP compared with controls. The other 20 genes, including SLC10A2 (ASBT) and EPHX1 (EPOX, mEH) reported for the first time in trophoblasts, were comparably abundant in healthy and ICP placentae. ABCG5 was undetectable in all placentae. Placental SLC10A2 (ASBT), SLCO4A1 (OATP4A1), and ABCC2 mRNA levels were positively correlated with BA concentrations in ICP. Placental SLC10A2 (ASBT) mRNA was also correlated with maternal body mass index. We conclude that at the transcriptional level only a limited response of BA transport systems is found under ICP conditions. However, the extent of the transcriptional response may also depend on the severity of the ICP condition and the magnitude by which the maternal BA levels are increased.